Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

April
27
2026

Basal Cell Carcinoma vs. Squamous Cell Carcinoma: What’s the Difference?

Melanoma and non-melanoma are two primary categories of skin cancer. Each presents different symptoms and treatment options. Within the non-melanoma skin cancer – sometimes referred to as NMSC – category, the two most common types…

July
24
2017

“I feel more alive:” FOX6 viewers’ generosity helps man get debilitating keloids treated after insurance denial

Treatment with Sensus Healthcare’s SRT-100™ following surgical removal of this man’s keloids reduced the chance of recurrence to just 4%. Click here to view the full article on FOX6NOW.com.  

July
11
2017

Advancing Keloid Treatment: A Novel Multimodal Approach to Ear Keloids

Michael E. Jones, MD,* Jennifer McLane, FNP,* Rachael Adenegan, FNP-C,* JoAnne Lee, PA-BC,*, and Christine A. Ganzer, PMHNP, PhD† BACKGROUND/OBJECTIVE Management of keloids of the pinna, in particular, those located in the helix and antihelix…

July
10
2017

Skin cancer treatment technology provides alternative to surgery for skin cancer patients

Skin cancer generally appears within the first two to three millimeters of the surface of the skin. “The traditional way to treat skin cancer is surgery,” said Dr. Jeffrey Brackeen, with the Skin Cancer Institute…

July
05
2017

Non-surgical local skin cancer treatment

The National Cancer Institute estimates 40-50% of Americans age 65 and over will have skin cancer at least once. Joe Sardano with Sensus Healthcare stopped by to tell us about its SRT technology the company…

Archives
Archives

IN THE NEWS

CEO Joseph Sardano on Coding for Superficial Radiation Therapy